LORBRENA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 7ef4ebbdfb42a223
Drug Approval Canada Name: LORBRENA
Product Name: LORBRENA
Status: Marketed
Status Date: 2019-04-22
Original Market Date: 2019-04-22
Din: 02485966
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01ED05 LORLATINIB
Atc Name: l 01 ed 05
Aig Number: 0161231001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

LORLATINIB

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7ef4ebbdfb42a223

Type

Standard